Investing in Vaccine Lifecycle Management in Africa towards Equal Access to Vaccines and Beyond
- 2022/8/26 (Fri)17:00-18:30（JST）
- Type of Event
- Online Webinar
The COVID-19 pandemic has posed unprecedented challenges in the deployment of health care products including vaccines, diagnostics, and therapeutics. Vaccination is a cornerstone of response to the spread of infectious diseases. Fast-tracked vaccine development and deployment at the global level have been seen as a significant success. However, with 99% of vaccines being imported, Africa remains overly dependent on imports of COVID-19 vaccines due to its limited capacity to manufacture vaccines locally.
To boost capacity for local vaccine production, there are on-going efforts to address the gap in vaccine production capacity. Toward ensuring equal access to vaccines, concerted efforts to enhance research and development, harmonize regulatory systems, and establish local vaccine manufacturing and delivery mechanisms that will lead to sustainable vaccine lifecycle management in Africa are needed.
To seek potential options to enhance vaccine lifecycle management in Africa, this event sheds light on the current progress of vaccine development and deployment in Africa with a particular focus on successes and challenges in research and development, regulatory systems and manufacturing. The event also endeavors to build the solid network of partners between Africa and Japan to explore opportunities for collaboration in order to create a robust enabling environment for vaccine lifecycle management from development to delivery that will ultimately contribute to resilient health security for all in Africa.
- What current progress, successes and challenges can be observed in research and development, regulation and manufacturing of vaccines in Africa and Japan?
- How can the capacity for research and development, regulatory systems and production be increased through collaborations between partners in Africa and Japan
- What are viable paths towards building a robust enabling environment for sustainable vaccine lifecycle management in Africa?
To develop, consolidate and broaden the network of partners between Africa and Japan by exchanging and generating ideas and key lessons related to vaccine lifecycle management with focus on R&D, regulatory systems and manufacturing, towards ensuring equitable access to vaccines in Africa.
- Dr. Ahmed Ogwell OUMA
- Acting Director, Africa CDC
- Prof. Dorothy YEBOAH-MANU
- Director, Noguchi Memorial Institute for Medical Research, Ghana
- Prof. Elijah SONGOK
- Director, Directorate of Research Capacity Building, Kenya Medical Research Institute (KEMRI)
- Mr. Eric KARIKARI-BOATENG
- Director Centre for Laboratory Services Research, Ghana Food and Drugs Authority (FDA)
- Ms. KANASUGI Utako
- Advocacy & External Networking Manager, MSF Japan
- Dr. Isaac CHIKWANHA
- Senior Director, Investment Strategy, Access & Delivery, lobal Health Innovative Technology (GHIT) Fund, Japan
- Mr. KOGA Daisuke
- Division Director, Pharmaceuticals and Medical Devices Agency (PMDA) Japan
- Pasteur Institute of Dakar (tbc)
- Mr. TAKIZAWA Ikuo
- Senior Director, Office for COVID-19 Response, Human Development Department, JICA
*The deadline for registration is 17:00, Thursday, August 25 (Japan time).